Correlation of storage symptoms or overactive bladder symptoms post transurethral resection of the prostate with the duration of catheter use in a patient with urinary retention due to benign prostate hyperplasia

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Aim: This study aims to find out the correlation of catheter use duration with the incidence of OABS post TURP in patients with urinary retention due to BPH.

Materials and Methods: An observational analytical research correlation with a cohort approach was carried out on 29 patients with urinary retention due to BPH post TURP in five hospitals in Padang from January to August 2019. Data collected included the characteristics and duration of catheter use, obtained through interviews using questionnaires, OABS were obtained based on the total score of the overactive bladder symptoms score (OABSS) standard questionnaire. The numerical variable measurement scale is between the duration of catheter use and OABSS post TURP with the Pearson test using IBM SPSS software v23.

Results: The average of catheter used duration was 14,9±8,0 days, and the total OABSS score was 4,7±2,5. Bivariate analysis showed a positive correlation with a weak strength between the duration of catheter used and the total OABSS score (Pearson’s correlation, r=0,396, p=0,033). The longer the catheter is used, the higher the total OABSS.

Conclusion: The longer the catheter used increase the incidence of OABS post TURP, it is necessary to shorten the duration of catheter use to decrease the incidence and severity of OABS in urinary retention due to BPH patients post TURP.

Texto integral

Acesso é fechado

Sobre autores

Alfindy Perdinan

Andalas University, Central General Hospital Dr. M. Djamil

Email: etriyelmyh@med.unand.ac.id
ORCID ID: 0009-0006-5929-245X

Urology Specialist Residency Program, Medical Faculty

Indonésia, Padang

Alvarino Alvarino

Andalas University, Central General Hospital Dr. M. Djamil

Email: etriyelmyh@med.unand.ac.id
ORCID ID: 0000-0002-2876-9861

Division of Urology, Department of Surgery, Medical Faculty

Indonésia, Padang

Cimi Ilmiawati

Andalas university

Email: etriyelmyh@med.unand.ac.id
ORCID ID: 0000-0001-5743-3331

Division of Environmental Toxicology, Department of Pharmacology, Medical Faculty

Indonésia, Padang

Etriyel Myh

Andalas University, Central General Hospital Dr. M. Djamil

Autor responsável pela correspondência
Email: etriyelmyh@med.unand.ac.id
ORCID ID: 0000-0003-0558-8504

Division of Urology, Department of Surgery, Medical Faculty

Rússia, Padang

Bibliografia

  1. Gravas S, Gacci M, Gratzke C, et al. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol. 2023;84(2):207-222. doi: 10.1016/j.eururo.2023.04.008.
  2. Welliver C, Helo S, McVary KT. Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate. Transl Androl Urol. 2017;6(4):695-703. doi: 10.21037/tau.2017.07.30.
  3. Serlin DC, Heidelbaugh JJ, Stoffel JT. Urinary Retention in Adults: Evaluation and Initial Management. Am Fam Physician. 2018;98(8):496-503.
  4. Anutrakulchai S. Residual LUTS after Transurethral Resection of Prostate (TURP ): The Urodynamic Studies in Chiangmai University. Thai J Surg. 2005; 26: 82–7.
  5. Zhang Z, Cao Z, Xu C, et al. Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors. Urology. 2014;84(1):117-121. doi: 10.1016/j.urology.2014.02.034.
  6. Gamé X, Phé V. Physiopathologie du syndrome clinique d’hyperactivité vésicale [Pathophysiology of overactive bladder]. Prog Urol. 2020;30(14):873-879. doi: 10.1016/j.purol.2020.08.003.
  7. Hu B, Li C, Pan M, et al. Strategies for the prevention of catheter-related bladder discomfort: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95(37):e4859. doi: 10.1097/MD.0000000000004859.
  8. Yadav G, Prashanth M, Singh RB, et al. Incidence and severity of catheter related bladder discomfort by using different inhalational anesthetic agents and comparing it with propofol. Anaesth Pain & Intensive Care 2015; 19(4): 452-456
  9. Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn. 2010; 29(1): 97-106. doi: 10.1002/nau.20784
  10. Bai Y, Wang X, Li X, et al. Management of Catheter-Related Bladder Discomfort in Patients Who Underwent Elective Surgery. J Endourol. 2015;29(6):640-649. doi: 10.1089/end.2014.0670.
  11. Maro S, Zarattin D, Baron T, Bourez S, de la Taille A, Salomon L. Inconfort lié à la sonde vésicale en postopératoire: importance du type d’intervention et efficacité du traitement par clonazépam [Catheter-related bladder discomfort after urological surgery: importance of the type of surgery and efficiency of treatment by clonazepam]. Prog Urol. 2014;24(10):628-633. doi: 10.1016/j.purol.2014.05.002.
  12. Li SY, Song LP, Ma YS, Lin XM. Predictors of catheter-related bladder discomfort after gynaecological surgery. BMC Anesthesiol. 2020;20(1):97. Published 2020 Apr 28. doi: 10.1186/s12871-020-01018-6.
  13. Manley KV, Hubbard R, Swallow D, Finch W, Wood SJ, Biers SM. Risk factors for development of primary bladder squamous cell carcinoma. Ann R Coll Surg Engl. 2017;99(2):155-160. doi: 10.1308/rcsann.2016.0343.
  14. Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013;93(2):653-680. doi: 10.1152/physrev.00030.2012.
  15. Ugare UG, Bassey IA, Udosen EJ, Essiet A, Bassey OO. Management of lower urinary retention in a limited resource setting. Ethiop J Health Sci. 2014;24(4):329-336. doi: 10.4314/ejhs.v24i4.8.
  16. Ma S, Gu J, Fan X. Need to clamp indwelling urinary catheters before removal after different durations: a systematic review and meta-analysis. BMJ Open. 2023;13(2):e064075. Published 2023 Feb 15. doi: 10.1136/bmjopen-2022-064075.
  17. Choi H, Kim JH, Shim JS, et al. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement. Urol Int. 2014;93(4):425-430. doi: 10.1159/000357626.
  18. Gacci M, Sebastianelli A, Spatafora P, et al. Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base. Ther Adv Urol. 2017;10(2):79-92. Published 2017 Dec 7. doi: 10.1177/1756287217742837
  19. Merrill L, Gonzalez EJ, Girard BM, Vizzard MA. Receptors, channels, and signalling in the urothelial sensory system in the bladder. Nat Rev Urol. 2016;13(4):193-204. doi: 10.1038/nrurol.2016.13.
  20. Moataz A, Chadli A, Wichou E, et al. Facteurs prédictifs de l’inconfort lié à la sonde vésicale [Predictors of catheter-related bladder discomfort]. Progrès en Urologie. 2020; 30(16): 1045-1050.
  21. Birder LA, de Groat WC. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol. 2007;4(1):46-54. doi: 10.1038/ncpuro0672.
  22. Fry CH, Vahabi B. The Role of the Mucosa in Normal and Abnormal Bladder Function. Basic Clin Pharmacol Toxicol. 2016;119 Suppl 3(Suppl 3):57-62. doi: 10.1111/bcpt.12626.
  23. Ramakrishnan K, Mold J. Urinary Catheters: A Review. Internet J Fam Pract. 2004; 3(2): 1–12. http://ispub.com/IJFP/3/2/4596

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2. Figure 1. Severity of respondents' overactive bladder symptoms (The majority of respondents in this study had mild OAB symptoms (52%). Respondents with moderate, severe and those who did not experience OAB were respectively; 28%, 3%, and 17% of all respondents)

Baixar (55KB)
Metadados
3. Figure 2. Correlation between duration of catheter use and total OABSS in patients with urinary retention due to BPH post TURP

Baixar (63KB)
Metadados

Declaração de direitos autorais © Bionika Media, 2025